ALB and hyperlipidemia: In group ADR, Adriamycin induced proteinuria, hypoalbuminemia (24hUPE: Group ADR: 59.93 ± 3.36 mg/24 h versus Group N: 10.71 ± 1.00 mg/24 h, *p < .05; TP: Group ADR: 42.39 ± 3.72 g/L versus Group N: 58.87 ± 7.77 g/L, *p < .05; ALB: Group ADR: 22.37 ± 1.44 g/L versus Group N: 39.16 ± 2.39 g/L, *p < .05) and hyperlipidemia (TG: 4.64 ± 0.73 mmol/L versus Group N, *p < .05; TC: 6.38 ± 0.65 mmol/L versus Group N, *p < .05; LDL: 2.21 ± 0.70 mmol/L versus Group N, *p < .05).